JD Health InternationalJDHIF 90 PB Ratio is 2.20 as of Jun. 29, 2026, which is 29% below its 10-year median of 3.11. GuruFocus rates JDHIF with a GF Score™ of 90/100 and a GF Value™ of $10.42. The stock has 1 warning sign investors should review. Among 608 Healthcare Providers & Services companies, JD Health International ranks better than 58.06% on this metric.
JD Health International Inc stock PB Ratio (=1.55) is close to 1-year low of 1.55.
The historical rank and industry rank for JD Health International's PB Ratio or its related term are showing as below:
JDHIF'
s PB Ratio Range Over the Past 10 Years
Min: 1.21 Med: 3.11 Max: 11.5
Current: 1.55
During the past 9 years, JD Health International's highest PB Ratio was 11.50. The lowest was 1.21. And the median was 3.11.
JDHIF's PB Ratio is ranked better than 58.06% of 608
companies
in the Healthcare Providers & Services industry
Industry Median: 1.985
vs JDHIF: 1.55
During the past 12 months, JD Health International's average Book Value Per Share Growth Rate was 12.20% per year.
During the past 3 years, the average Book Value Per Share Growth Rate was 9.60% per year.
During the past 5 years, the average Book Value Per Share Growth Rate was 7.00% per year.
During the past 9 years, the highest 3-Year average Book Value Per Share Growth Rate of JD Health International was 287.60% per year. The lowest was 5.00% per year. And the median was 9.60% per year.
Back to Basics: PB Ratio
JD Health International (OTCPK:JDHIF) PB Ratio Explanation
The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
JD Health International PB Ratio Competitor Comparison
For the Pharmaceutical Retailers subindustry, JD Health International's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
JD Health International PB Ratio vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, JD Health International's PB Ratio distribution charts can be found below:
* The bar in red indicates where JD Health International's PB Ratio falls into.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.
JD Health International (JDHIF) has a PB Ratio of 2.20 as of Jun. 29, 2026. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on JD Health International and its competitors. This is 29% below median its historical median of 3.11. Over the past decade, JD Health International's PB Ratio has ranged from 1.21 to 11.50. According to the industry distribution chart, JD Health International ranks #255 out of 608 companies in the Healthcare Providers & Services industry, placing it in the top 41.9%.
Is JD Health International's PB Ratio too high?
JD Health International's current PB Ratio of 2.20 is 29% below median its 10-year median of 3.11. Over the past 10 years, this metric has ranged from a low of 1.21 to a high of 11.50. The Healthcare Providers & Services industry median PB Ratio is 1.99. JD Health International's value of 2.20 is 10.8% above this industry median. Based on the distribution chart, JD Health International ranks #255 out of 608 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, JD Health International has a GF Score™ of 90/100, reflecting its overall financial health beyond just this single metric.
How does JD Health International's PB Ratio compare to competitors?
According to the Healthcare Providers & Services industry distribution chart, JD Health International ranks #255 out of 608 companies for PB Ratio. This puts JD Health International in the upper half of its industry. The industry median PB Ratio is 1.99. JD Health International's value of 2.20 is 10.8% above this benchmark. Historically, JD Health International's own PB Ratio has ranged from 1.21 to 11.50 over the past decade. While the company's 10-year median is 3.11 vs. the industry median of 1.99, JD Health International has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PB Ratio for a Healthcare Providers & Services company?
The median PB Ratio among Healthcare Providers & Services companies is 1.99, based on 608 companies in the industry. Companies in the top quartile (top 25%) have a PB Ratio significantly above this median, while those in the bottom quartile fall well below. However, PB Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. JD Health International's current PB Ratio of 2.20 is 10.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PB Ratio mean?
A high PB Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on JD Health International and its competitors. For the Healthcare Providers & Services industry, the median PB Ratio is 1.99 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. JD Health International's current PB Ratio is 2.20, which is 29% below median its own 10-year median of 3.11. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is JD Health International stock overvalued right now?
JD Health International (JDHIF) has a current PB Ratio of 2.20. The stock's GF Value™ is $10.42, compared to a current price of $5.85 — trading 43.9% below its estimated fair value. The current PB Ratio is 2.20, which is 29% below median its 10-year median of 3.11 and 10.8% above the Healthcare Providers & Services industry median of 1.99. JD Health International's overall GF Score™ is 90/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PB Ratio calculated?
PB Ratio is calculated from a company's financial statements. For JD Health International (JDHIF), the current PB Ratio is 2.20 as of Jun. 29, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is JD Health International (JDHIF) Overvalued in 2026?
Based on GuruFocus' analysis, JD Health International stock appears to be undervalued.
The current stock price of $5.85 is trading 43.9% below its estimated GF Value™ of $10.42.
Key valuation signals for JDHIF:
PB Ratio: 2.20 (29% below median its 10-year median of 3.11)
GF Value™: $10.42 vs. price of $5.85 (43.9% below fair value)
Industry Position: 10.8% above the Healthcare Providers & Services median (#255 of 608)
No single metric tells the full story. See the JDHIF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
JD Health is the largest healthcare e-commerce platform in China in terms of revenue. The company offers pharmaceutical drugs and healthcare products on its platform, both as a marketplace that connects merchants to consumers and as a first-party, or 1P, direct retailer. It also offers online consultation from real life doctors and separately partners with offline pharmacies that can provide location-based 24/7 delivery as part of an omnichannel initiative to complement its core e-commerce business. Its closest competitors are Alibaba Health and Meituan for its e-commerce business. As of Dec. 31, 2024, the platform has over 200 million active annual users and over 70,000 merchants. JD Health is 67.49% owned by its parent company, JD.com.
90GF Score
Get the complete analysis for JDHIF
PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
JDHIF has been successfully added to your 
